Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-angiogenic therapy for osteosarcoma.

Gerald M Y Quan1, Peter F M Choong

  • 1Department of Orthopaedics, University of Melbourne, St. Vincent's Hospital Melbourne, P O Box 2900, Fitzroy 3065, Australia.

Cancer Metastasis Reviews
|December 13, 2006
PubMed
Summary

Novel therapies are needed for osteosarcoma, a bone cancer with stagnant survival rates. Cartilage-derived anti-angiogenic factors show promise as an adjunct to conventional treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2025 ICM: Debridement, Antibiotics, and Implant Retention.

The Journal of arthroplasty·2025
Same author

Impact of post-bariatric lipoabdominoplasty on knee and hip function: A biomechanical and symptomatic analysis.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2025
Same author

Advanced topology optimisation for porous hip Implants: Bridging in silico models and in vitro tests.

Journal of the mechanical behavior of biomedical materials·2025
Same author

National Trends in Glucagon-Like Peptide-1 Receptor Agonist Use in Adults Without Diabetes, 2018 to 2022.

Annals of internal medicine·2025
Same author

Validation of the Clavien-Dindo classification and Comprehensive Complication Index as measures of morbidity following total hip and knee arthroplasty.

The bone & joint journal·2024
Same author

Cutting the excess: tackling unnecessary orthopaedic surgeries.

ANZ journal of surgery·2024

Area of Science:

  • Oncology
  • Biomedical Research
  • Cancer Therapy

Background:

  • Osteosarcoma survival rates have plateaued despite established treatment protocols.
  • Conventional chemotherapy for osteosarcoma presents challenges including toxicity and limited efficacy in some cases.
  • There is a critical need for novel therapeutic strategies to improve patient outcomes.

Purpose of the Study:

  • To explore the potential of anti-angiogenic therapy as an adjunct treatment for osteosarcoma.
  • To investigate cartilage-derived anti-angiogenic factors for therapeutic applications in osteosarcoma.
  • To identify novel strategies to overcome limitations of current osteosarcoma treatments.

Main Methods:

  • Review of existing literature on osteosarcoma treatment and anti-angiogenic therapies.
  • Analysis of the role of cartilage as a natural barrier to tumor invasion.
  • Exploration of the therapeutic potential of cartilage-derived anti-angiogenic factors.

Main Results:

  • Anti-angiogenic therapy demonstrates significant potential when combined with conventional osteosarcoma treatments.
  • Cartilage-derived factors possess anti-angiogenic properties relevant to inhibiting osteosarcoma progression.
  • These factors may help reduce chemotherapy toxicity and combat metastatic disease.

Conclusions:

  • Anti-angiogenic therapy, particularly using cartilage-derived factors, offers a promising avenue for improving osteosarcoma treatment.
  • Further research into these factors could lead to more effective and less toxic therapeutic options.
  • Targeting angiogenesis presents a viable strategy to enhance current osteosarcoma management.

Related Experiment Videos